Strengthen already existing vaccine technologies

with an exclusivity IP on targeted application

Co-development of new vaccines

for emerging applications on specific species

We provide preclinical and clinical services to potentialize your vaccines with CyaA (AC-) technology and unique companion animal immunomonitoring platform

We propose to co-develop new vaccines for unmet needs untill the commercial authorization